Difference between revisions of "Elafin (TG3)"
m |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Elafin.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | Elafin |
|- | |- | ||
| Synonyms | | Synonyms | ||
| Line 24: | Line 24: | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | [[ | + | | [[TG2 reactive residues (Elafin)|Q2 Q59]] |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| − | | [[ | + | | [[TG2 reactive residues (Elafin)|K6]] |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| Line 51: | Line 51: | ||
| | | | ||
|- | |- | ||
| − | | {{infobox header | + | | Video |
| + | |{{#ev:dailymotion|ot2lRay5hDTBDkXRI|300}} | ||
| + | |- | ||
| + | | {infobox header} | | ||
|- | |- | ||
|} | |} | ||
[[Category:Epidermal transglutaminase|*]] | [[Category:Epidermal transglutaminase|*]] | ||
Latest revision as of 12:03, 10 March 2015
| Elafin (TG3) | |
|---|---|
| |
| Substrate peptide name | Elafin |
| Synonyms | Cementoin
Elastase-specific inhibitor |
| Determination type | In situ/In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cornified evelope |
| Swissprot ID | P19957 |
| Reactive glutamines | Q2 Q59 |
| Reactive lysines | K6 |
| Substrate sequence | AQEPVKGPV
ACFVPQ |
| Structure | 2REL |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:7543090 |
| Notes | |
| Video | ot2lRay5hDTBDkXRI|300}} |
